Matches in Nanopublications for { ?s ?p "[We examined whether genetic variation in ADIPOR2 predicts the development of cardiovascular disease (CVD) and/or Type 2 Diabetes (T2DM) in individuals with impaired glucose tolerance (IGT) participating the Finnish Diabetes Prevention Study (DPS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP201560.RADqtglxxSA8ji7of2x0S-NEwleWxNE3cYRohSJhjP0Sw130_assertion description "[We examined whether genetic variation in ADIPOR2 predicts the development of cardiovascular disease (CVD) and/or Type 2 Diabetes (T2DM) in individuals with impaired glucose tolerance (IGT) participating the Finnish Diabetes Prevention Study (DPS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201560.RADqtglxxSA8ji7of2x0S-NEwleWxNE3cYRohSJhjP0Sw130_provenance.
- NP159515.RATKhvH5CHK472afusmNEddB02uNXyGoBq84amYBLTm70130_assertion description "[We examined whether genetic variation in ADIPOR2 predicts the development of cardiovascular disease (CVD) and/or Type 2 Diabetes (T2DM) in individuals with impaired glucose tolerance (IGT) participating the Finnish Diabetes Prevention Study (DPS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP159515.RATKhvH5CHK472afusmNEddB02uNXyGoBq84amYBLTm70130_provenance.
- NP667113.RAjz6GyiVHUWVrUqX8uQKtD7egkHvdn_ZFDz2icgbWSKc130_assertion description "[We examined whether genetic variation in ADIPOR2 predicts the development of cardiovascular disease (CVD) and/or Type 2 Diabetes (T2DM) in individuals with impaired glucose tolerance (IGT) participating the Finnish Diabetes Prevention Study (DPS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667113.RAjz6GyiVHUWVrUqX8uQKtD7egkHvdn_ZFDz2icgbWSKc130_provenance.
- NP740166.RAscrdn8XfanFX37uHMdpycxGoerNPLQ1Mu_bqnqCD05M130_assertion description "[We examined whether genetic variation in ADIPOR2 predicts the development of cardiovascular disease (CVD) and/or Type 2 Diabetes (T2DM) in individuals with impaired glucose tolerance (IGT) participating the Finnish Diabetes Prevention Study (DPS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740166.RAscrdn8XfanFX37uHMdpycxGoerNPLQ1Mu_bqnqCD05M130_provenance.
- NP906134.RAfwIRTqFeqKehatS8Rk3Mgcnub22oxM7xl1I6Vj3Alxk130_assertion description "[We examined whether genetic variation in ADIPOR2 predicts the development of cardiovascular disease (CVD) and/or Type 2 Diabetes (T2DM) in individuals with impaired glucose tolerance (IGT) participating the Finnish Diabetes Prevention Study (DPS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906134.RAfwIRTqFeqKehatS8Rk3Mgcnub22oxM7xl1I6Vj3Alxk130_provenance.
- NP874170.RAXdI6Rh01Spcyu5SZeYzt99jfcW6MGj1CbmTqaRStvcA130_assertion description "[We examined whether genetic variation in ADIPOR2 predicts the development of cardiovascular disease (CVD) and/or Type 2 Diabetes (T2DM) in individuals with impaired glucose tolerance (IGT) participating the Finnish Diabetes Prevention Study (DPS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874170.RAXdI6Rh01Spcyu5SZeYzt99jfcW6MGj1CbmTqaRStvcA130_provenance.
- NP298183.RAxtcwpHxizSeItSnJJDMGCguW6KhQ12JNgXiZSInvsmk130_assertion description "[We examined whether genetic variation in ADIPOR2 predicts the development of cardiovascular disease (CVD) and/or Type 2 Diabetes (T2DM) in individuals with impaired glucose tolerance (IGT) participating the Finnish Diabetes Prevention Study (DPS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298183.RAxtcwpHxizSeItSnJJDMGCguW6KhQ12JNgXiZSInvsmk130_provenance.